Reducing Empiric VAncomycin Use in Pediatric Suspected Sepsis

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorChildren's Hospital of Philadelphia

About this trial

The goal of this quasi-experimental interventional study is to determine the effectiveness of a multifaceted stewardship intervention in reducing overall vancomycin use in five tertiary care Pediatric Intensive Care Units (PICU).

There are two groups of subjects in this study: PICU clinicians/sepsis stakeholders and patients admitted to one of the participating PICUs during the study period. The intervention will at a minimum include:

* Implementation of a clinical guideline indicating when vancomycin should and should not be used * Unit-level feedback on overall vancomycin use within and across centers * Clinician education.

Eligibility criteria

Qualifiers

Admitted to one of the participating PICUs during the study period

Disqualifiers

None

PICU prescribing clinician (including attending physicians, fellows, residents, nurse practitioners, and physician assistants) OR sepsis stakeholder (leader of sepsis quality improvement work, medical director) at one of the participating sites at the time the survey is deployed

Age ≥ 18 years old

Employed by one of the participating sites

Trial design

Treatments tested in this trial

  • Multifaceted de-implementation strategy to reduce vancomycin overuse

Treatment groups

52,500 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Children's Hospital of Philadelphia

Lead sponsor

Children's Healthcare of Atlanta

Collaborator

St. Louis Children's Hospital

Collaborator

Johns Hopkins University

Collaborator

University of Pennsylvania

Collaborator

Centers for Disease Control and Prevention

Collaborator